MedTrace Logo

Bupropion in the Treatment of Pathological Gambling

NCT00055393 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-03-14

No results posted yet for this study

Summary

This study will determine whether the drug bupropion is an effective treatment for Pathological Gambling.

Conditions

  • Pathological Gambling

Interventions

DRUG

Bupropion

18 subjects in this randomly controlled double blind study received bupropion.

DRUG

Placebo

21 subjects received Placebo.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of Iowa

    lead OTHER

Principal Investigators

  • Donald W Black, MD · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-07-31
Primary Completion
2005-05-31
Completion
2006-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00055393 on ClinicalTrials.gov